Halozyme Therapeutics Quick Ratio 2010-2024 | HALO

Halozyme Therapeutics quick ratio for the quarter ending September 30, 2024 was 9.14.

  • Halozyme Therapeutics average quick ratio for 2023 was 5.76, a 12.06% increase from 2022.
  • Halozyme Therapeutics average quick ratio for 2022 was 5.14, a 36.62% increase from 2021.
  • Halozyme Therapeutics average quick ratio for 2021 was 8.11, a 27.98% decline from 2020.

Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.

Halozyme Therapeutics Quick Ratio 2010-2024 | HALO

  • Halozyme Therapeutics average quick ratio for 2023 was 5.76, a 12.06% increase from 2022.
  • Halozyme Therapeutics average quick ratio for 2022 was 5.14, a 36.62% increase from 2021.
  • Halozyme Therapeutics average quick ratio for 2021 was 8.11, a 27.98% decline from 2020.

Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.